154 related articles for article (PubMed ID: 29870276)
21. Mismatch repair protein expression is an independent prognostic factor in sporadic colorectal cancer.
Ohrling K; Edler D; Hallström M; Ragnhammar P
Acta Oncol; 2010 Aug; 49(6):797-804. PubMed ID: 20307245
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5.
Li PL; Zhang X; Wang LL; Du LT; Yang YM; Li J; Wang CX
Carcinogenesis; 2015 Dec; 36(12):1484-93. PubMed ID: 26442524
[TBL] [Abstract][Full Text] [Related]
23. Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy.
Edler D; Glimelius B; Hallström M; Jakobsen A; Johnston PG; Magnusson I; Ragnhammar P; Blomgren H
J Clin Oncol; 2002 Apr; 20(7):1721-8. PubMed ID: 11919227
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
[TBL] [Abstract][Full Text] [Related]
25. Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapy.
Han Y; Cai H; Ma L; Ding Y; Tan X; Liu Y; Su T; Yu Y; Chang W; Zhang H; Fu C; Cao G
Eur J Cancer; 2013 Nov; 49(16):3420-30. PubMed ID: 23809767
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of LncRNA-RP11-317J10.2 promotes cell proliferation and invasion and predicts poor prognosis in colorectal cancer.
Luo J; Xu LN; Zhang SJ; Jiang YG; Zhuo DX; Wu LH; Jiang X; Huang Y
Scand J Gastroenterol; 2018 Jan; 53(1):38-45. PubMed ID: 29073791
[TBL] [Abstract][Full Text] [Related]
27. Elevated OCT1 participates in colon tumorigenesis and independently predicts poor prognoses of colorectal cancer patients.
Wang YP; Song GH; Chen J; Xiao C; Li C; Zhong L; Sun X; Wang ZW; Deng GL; Yu FD; Xue YM; Tang HM; Peng ZH; Wang XL
Tumour Biol; 2016 Mar; 37(3):3247-55. PubMed ID: 26433389
[TBL] [Abstract][Full Text] [Related]
28. Validation of biomarkers associated with 5-fluorouracil and thymidylate synthase in colorectal cancer.
Xi Y; Formentini A; Nakajima G; Kornmann M; Ju J
Oncol Rep; 2008 Jan; 19(1):257-62. PubMed ID: 18097604
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of BIRC6 Is a Predictor of Prognosis for Colorectal Cancer.
Hu T; Weng S; Tang W; Xue R; Chen S; Cai G; Cai Y; Shen X; Zhang S; Dong L
PLoS One; 2015; 10(5):e0125281. PubMed ID: 25933218
[TBL] [Abstract][Full Text] [Related]
30. Loss of ABCB4 attenuates the caspase-dependent apoptosis regulating resistance to 5-Fu in colorectal cancer.
Hu H; Wang M; Guan X; Yuan Z; Liu Z; Zou C; Wang G; Gao X; Wang X
Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29371412
[TBL] [Abstract][Full Text] [Related]
31. SCGB2A1 is a novel prognostic marker for colorectal cancer associated with chemoresistance and radioresistance.
Munakata K; Uemura M; Takemasa I; Ozaki M; Konno M; Nishimura J; Hata T; Mizushima T; Haraguchi N; Noura S; Ikenaga M; Okamura S; Fukunaga M; Murata K; Yamamoto H; Doki Y; Mori M
Int J Oncol; 2014 May; 44(5):1521-8. PubMed ID: 24585249
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of sortilin is associated with 5-FU resistance and poor prognosis in colorectal cancer.
Blondy S; Talbot H; Saada S; Christou N; Battu S; Pannequin J; Jauberteau MO; Lalloué F; Verdier M; Mathonnet M; Perraud A
J Cell Mol Med; 2021 Jan; 25(1):47-60. PubMed ID: 33325631
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of HOXA10 in gastric cancer with the intestinal mucin phenotype: reduction during tumor progression and favorable prognosis.
Sentani K; Oue N; Naito Y; Sakamoto N; Anami K; Oo HZ; Uraoka N; Aoyagi K; Sasaki H; Yasui W
Carcinogenesis; 2012 May; 33(5):1081-8. PubMed ID: 22411957
[TBL] [Abstract][Full Text] [Related]
34. WNT5A Promoter Methylation Is Associated with Better Responses and Longer Progression-Free Survival in Colorectal Cancer Patients Treated with 5-Fluorouracil-Based Chemotherapy.
Jiang G; Lin J; Wang W; Sun M; Chen K; Wang F
Genet Test Mol Biomarkers; 2017 Feb; 21(2):74-79. PubMed ID: 28051879
[TBL] [Abstract][Full Text] [Related]
35. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.
Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E
JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222
[TBL] [Abstract][Full Text] [Related]
36. Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patients.
Zhang Q; Wang XQ; Wang J; Cui SJ; Lou XM; Yan B; Qiao J; Jiang YH; Zhang LJ; Yang PY; Liu F
Oncotarget; 2015 Jun; 6(17):15095-110. PubMed ID: 25945835
[TBL] [Abstract][Full Text] [Related]
37.
Lapucci A; Perrone G; Di Paolo A; Napoli C; Landini I; Roviello G; Calosi L; Naccarato AG; Falcone A; Bani D; Mini E; Nobili S
Oncol Res; 2021 Mar; 28(6):631-644. PubMed ID: 33208224
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of NOX4 predicts poor prognosis and promotes tumor progression in human colorectal cancer.
Lin XL; Yang L; Fu SW; Lin WF; Gao YJ; Chen HY; Ge ZZ
Oncotarget; 2017 May; 8(20):33586-33600. PubMed ID: 28422720
[TBL] [Abstract][Full Text] [Related]
39. High expression of Zinc-finger protein X-linked promotes tumor growth and predicts a poor outcome for stage II/III colorectal cancer patients.
Yan X; Shan Z; Yan L; Zhu Q; Liu L; Xu B; Liu S; Jin Z; Gao Y
Oncotarget; 2016 Apr; 7(15):19680-92. PubMed ID: 26967242
[TBL] [Abstract][Full Text] [Related]
40. Elevated Expression of ERCC6 Confers Resistance to 5-Fluorouracil and Is Associated with Poor Patient Survival in Colorectal Cancer.
Zhao Z; Zhang G; Li W
DNA Cell Biol; 2017 Sep; 36(9):781-786. PubMed ID: 28665687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
